Plasma levels of endocannabinoids and their analogues as potential markers of cardiometabolic riskLicense Agreement • February 3rd, 2023
Contract Type FiledFebruary 3rd, 2023Xinyu Di*, Borja Martinez-Tellez*, Elke H.J. Krekels, Lucas Jurado-Fasoli, Francisco J. Osuna-Prieto, Lourdes Ortiz-Alvarez, Amy C. Harms, Jose V. Garcia- Lario, Thomas Hankemeier, Patrick C.N. Rensen, Jonatan R. Ruiz, Isabelle Kohler